Michele Alessandro Coceani

Dr. Michele Alessandro Coceani


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAngela Buonpane
Angela Buonpane
Giancarlo TrimarchiGiancarlo Trimarchi
Giancarlo Trimarchi
MCMarco Ciardetti
Marco Ciardetti
MCMichele Alessandro Coceani
Michele Alessandro Coceani
Giulia AlagnaGiulia Alagna
Giulia Alagna
ACAlberto Ranieri De Caterina
Alberto Ranieri De Caterina
In acute myocardial infarction (AMI), the urgency of coronary revascularization through percutaneous coronary intervention (PCI) is paramount, offering notable advantages over pharmacologic treatment. However, the persistent risk of adverse events, including recurrent AMI and heart failure post-revascularization, underscores the necessity for enhanced strategies in managing coronary artery disease. Traditional angiography, while widely employed, presents significant limitations by providing only two-dimensional representations of complex three-dimensional vascular structures, hampering the accurate assessment of plaque characteristics and stenosis severity. Intravascular imaging, specifically optical coherence tomography (OCT), significantly addresses these limitations with superior spatial resolution compared to intravascular ultrasound (IVUS). Within the context of AMI, OCT serves dual purposes: as a diagnostic tool to accurately identify culprit lesions in ambiguous cases and as a guide for optimizing PCI procedures. Its capacity to differentiate between various mechanisms of acute coronary syndrome, such as plaque rupture and spontaneous coronary dissection, enhances its diagnostic potential. Furthermore, OCT facilitates precise lesion preparation, optimal stent sizing, and confirms stent deployment efficacy. Recent meta-analyses indicate that OCT-guided PCI markedly improves safety and efficacy in revascularization, subsequently decreasing the risks of mortality and complications. This review emphasizes the critical role of OCT in refining patient-specific therapeutic approaches, aligning with the principles of precision medicine to enhance clinical outcomes for individuals experiencing AMI.

1 October 2012 in Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
MCMichele Alessandro Coceani
Michele Alessandro Coceani
The thyroid and the cardiovascular system are closely related, both in physiological and pathological conditions. The adverse consequences on the heart of overt thyroid disease are well-known and even subclinical forms of both hyperthyroidism and hypothyroidism are associated with increased cardiovascular mortality. In recent years, attention has shifted towards milder forms of thyroid disease, such as the so-called "low T3 syndrome", which is characterized by an isolated reduction in circulating levels of the biologically active form of thyroid hormone, triiodothyronine (T3). Furthermore, variations of T3 within the physiological range have been linked to coronary artery disease, one of the leading causes of morbidity and mortality worldwide. The present manuscript provides an overview of thyroid physiology and pathophysiology, with a particular focus on cardiovascular disease in patients with milder forms of thyroid dysfunction.

3 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAngela Buonpane
Angela Buonpane
ACAlberto Ranieri De Caterina
Alberto Ranieri De Caterina
Giancarlo TrimarchiGiancarlo Trimarchi
Giancarlo Trimarchi
Fausto PizzinoFausto Pizzino
Fausto Pizzino
MCMarco Ciardetti
Marco Ciardetti
FCFilippo Crea
Filippo Crea
Plaque erosion (PE) is now recognized as a common and clinically significant cause of acute coronary syndromes (ACSs), accounting for up to 40% of cases. Unlike plaque rupture (PR), PE involves superficial endothelial loss over an intact fibrous cap and occurs in a low-inflammatory setting, typically affecting younger patients, women, and smokers with fewer traditional risk factors. The growing recognition of PE has been driven by high-resolution intracoronary imaging, particularly optical coherence tomography (OCT), which enables in vivo differentiation from PR. Identifying PE with OCT has opened the door to personalized treatment strategies, as explored in recent trials evaluating the safety of deferring stent implantation in selected cases in favor of intensive medical therapy. Given its unexpectedly high prevalence, PE is now recognized as a common pathophysiological mechanism in ACS, rather than a rare exception. This growing awareness underscores the importance of its accurate identification through OCT in clinical practice. Early recognition and a deeper understanding of PE are essential steps toward the implementation of precision medicine, allowing clinicians to move beyond “one-size-fits-all” models toward “mechanism-based” therapeutic strategies. This narrative review aims to offer an integrated overview of PE, tracing its epidemiology, elucidating the molecular and pathophysiological mechanisms involved, outlining its clinical presentations, and placing particular emphasis on diagnostic strategies with OCT, while also discussing emerging therapeutic approaches and future directions for personalized cardiovascular care.

16 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAngela Buonpane
Angela Buonpane
MCMarco Ciardetti
Marco Ciardetti
Giancarlo TrimarchiGiancarlo Trimarchi
Giancarlo Trimarchi
GSGiancarla Scalone
Giancarla Scalone
MCMichele Alessandro Coceani
Michele Alessandro Coceani
ACAlberto Ranieri De Caterina
Alberto Ranieri De Caterina
Sodium–glucose cotransporter 2 inhibitors (SGLT2is) have revolutionized the treatment of heart failure and are now established as disease-modifying therapies across the spectrum of left ventricular ejection fraction. More recently, these agents have been evaluated in the early post-acute myocardial infarction (AMI) setting, raising interest in their potential role beyond heart failure prevention. Evidence from post-AMI randomized trials and contemporary meta-analyses consistently shows neutral effects on ischemic coronary outcomes, despite favorable effects on heart failure-related endpoints, ventricular remodeling, and cardiometabolic parameters. At the same time, data from experimental and translational research provide a biological framework in which SGLT2i exert anti-atherogenic effects through multiple complementary mechanisms, including improvement of cardiometabolic risk factors, attenuation of vascular and systemic inflammation, modulation of endothelial function, regulation of vascular smooth muscle cell behavior, macrophage inflammatory polarization, inhibition of inflammasome signaling, and modulation of the perivascular adipose tissue–vascular interface. Taken together, the available evidence highlights a dissociation between clinical trial outcomes in the early post-AMI phase and the underlying vascular biology associated with SGLT2 inhibition. While the dominant early clinical effects of SGLT2i appear to relate to hemodynamic and heart failure-preventive mechanisms, their potential impact on atherosclerotic disease may be more gradual and context-dependent. This review summarizes current clinical and mechanistic evidence supporting this interpretation and discusses the implications for understanding the role of SGLT2i in patients after AMI.

1 January 2013 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
MCMichele Alessandro Coceani
Michele Alessandro Coceani
MCMarco Ciardetti
Marco Ciardetti
EPEmilio Pasanisi
Emilio Pasanisi
MSMathis Schlueter
Mathis Schlueter
CPCataldo Palmieri
Cataldo Palmieri
DRDaniele Rovai
Daniele Rovai

1 March 2016 in Journal of Electrocardiology
Verified
Journal Article
Closed access
DRDaniele Rovai
Daniele Rovai
AGAlessia Gimelli
Alessia Gimelli
MCMichele Alessandro Coceani
Michele Alessandro Coceani
FSFrancesco Sbrana
Francesco Sbrana
GMGABRIELE MASINI
GABRIELE MASINI
GRGiuseppe Rossi
Giuseppe Rossi